Jian Xu Selected Research

Jian Xu Research Topics

Disease

195	Neoplasms (Cancer) 11/2022 - 09/2002
52	Infections 05/2022 - 07/2003
37	Inflammation (Inflammations) 07/2022 - 06/2008
32	Neoplasm Metastasis (Metastasis) 01/2022 - 10/2008
25	Hepatocellular Carcinoma (Hepatoma) 01/2022 - 09/2002
22	Pancreatic Neoplasms (Pancreatic Cancer) 11/2022 - 04/2014
20	Colorectal Neoplasms (Colorectal Cancer) 04/2022 - 07/2014
20	Carcinogenesis 01/2022 - 01/2002
20	Fibrosis (Cirrhosis) 01/2022 - 02/2002
16	Body Weight (Weight, Body) 03/2022 - 01/2004
16	Colonic Neoplasms (Colon Cancer) 11/2021 - 03/2005
15	Pain (Aches) 03/2022 - 06/2010
14	Hypertension (High Blood Pressure) 01/2022 - 11/2003
14	Hemorrhage 08/2021 - 09/2003
13	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022 - 01/2012
13	Alzheimer Disease (Alzheimer's Disease) 11/2021 - 04/2004
13	Stomach Neoplasms (Stomach Cancer) 11/2021 - 06/2006
13	Lung Neoplasms (Lung Cancer) 01/2021 - 08/2009
12	Heart Failure 10/2022 - 01/2004
12	Wounds and Injuries (Trauma) 03/2022 - 09/2011
12	Cardiovascular Diseases (Cardiovascular Disease) 01/2022 - 03/2007
12	Myocardial Infarction 01/2022 - 01/2004
12	Hypoxia (Hypoxemia) 01/2022 - 11/2009
12	Stroke (Strokes) 01/2022 - 05/2008
12	Tuberculosis (Tuberculoses) 01/2022 - 11/2011
12	Carcinoma (Carcinomatosis) 01/2022 - 04/2011
11	Infarction (Infarctions) 01/2022 - 02/2006
11	Breast Neoplasms (Breast Cancer) 01/2022 - 01/2016
11	Ischemia 01/2021 - 02/2006
10	Rheumatoid Arthritis 10/2022 - 06/2008
10	Insulin Resistance 09/2022 - 06/2009
10	Type 2 Diabetes Mellitus (MODY) 03/2022 - 01/2013
10	Hypertrophy 01/2021 - 01/2004
10	Obesity 01/2021 - 02/2013
9	COVID-19 03/2022 - 01/2020
9	Atherosclerosis 01/2022 - 01/2005
9	Thyroid Diseases (Thyroid Disease) 01/2022 - 01/2006
9	Glioma (Gliomas) 01/2020 - 06/2004
8	Liver Neoplasms (Liver Cancer) 01/2022 - 01/2012
8	Adenocarcinoma 01/2022 - 06/2006
8	Asthma (Bronchial Asthma) 03/2021 - 05/2009
8	Cardiomegaly (Heart Hypertrophy) 01/2021 - 01/2004
8	Autoimmune Diseases (Autoimmune Disease) 01/2019 - 02/2014
7	Virus Diseases (Viral Diseases) 01/2022 - 05/2006
7	Cognitive Dysfunction 11/2021 - 01/2016
7	Diabetes Mellitus 09/2021 - 02/2006
7	Necrosis 06/2021 - 09/2014
7	Thrombosis (Thrombus) 03/2021 - 12/2003
7	Schizophrenia (Dementia Praecox) 02/2021 - 03/2012
7	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2021 - 09/2010
7	Lymphatic Metastasis 01/2021 - 10/2011
6	Pneumonia (Pneumonitis) 02/2022 - 11/2010
6	Liver Cirrhosis (Hepatic Cirrhosis) 01/2022 - 04/2002

Drug/Important Bio-Agent (IBA)

96	Proteins (Proteins, Gene)FDA Link 06/2022 - 12/2002
31	Pharmaceutical PreparationsIBA 01/2022 - 08/2004
31	Messenger RNA (mRNA)IBA 01/2022 - 03/2005
30	Biomarkers (Surrogate Marker)IBA 06/2022 - 02/2011
29	MicroRNAs (MicroRNA)IBA 06/2022 - 02/2011
26	Biological ProductsIBA 10/2022 - 10/2004
21	Long Noncoding RNAIBA 06/2022 - 01/2017
18	Therapeutic UsesIBA 02/2022 - 04/2002
17	Small Interfering RNA (siRNA)IBA 11/2021 - 05/2010
15	Glucose (Dextrose)FDA LinkGeneric 09/2022 - 12/2005
14	Insulin (Novolin)FDA Link 03/2022 - 12/2003
13	Interleukin-6 (Interleukin 6)IBA 11/2022 - 01/2013
13	CytokinesIBA 07/2022 - 10/2004
13	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 06/2005
13	LipidsIBA 09/2021 - 09/2011
12	Indicators and Reagents (Reagents)IBA 01/2022 - 01/2011
12	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 01/2022 - 03/2008
11	RNA (Ribonucleic Acid)IBA 06/2022 - 09/2002
11	Phosphotransferases (Kinase)IBA 01/2022 - 07/2013
11	Transcription Factors (Transcription Factor)IBA 01/2022 - 09/2002
10	CollagenIBA 01/2022 - 05/2005
10	EnzymesIBA 11/2021 - 09/2003
10	Protein Tyrosine PhosphatasesIBA 01/2020 - 05/2008
9	Phosphoric Monoester Hydrolases (Phosphatases)IBA 01/2019 - 10/2007
8	Blood Glucose (Blood Sugar)IBA 03/2022 - 09/2007
8	VaccinesIBA 01/2022 - 12/2009
8	AntigensIBA 01/2021 - 06/2008
8	Caspase 3 (Caspase-3)IBA 01/2021 - 01/2013
8	LipopolysaccharidesIBA 01/2020 - 06/2013
8	Tyrosine (L-Tyrosine)FDA Link 01/2019 - 09/2009
7	Anti-Bacterial Agents (Antibiotics)IBA 01/2022 - 08/2010
7	Circular RNAIBA 11/2021 - 01/2018
7	Eosine Yellowish-(YS) (Eosin)IBA 10/2021 - 07/2013
7	Hematoxylin (Haematoxylon)IBA 10/2021 - 07/2013
7	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 06/2021 - 10/2003
6	FlavonoidsIBA 04/2022 - 04/2013
6	Streptozocin (Streptozotocin)FDA Link 03/2022 - 08/2007
6	MonocrotalineIBA 01/2022 - 12/2016

Therapy/Procedure

84	Therapeutics 10/2022 - 09/2003
29	Drug Therapy (Chemotherapy) 07/2022 - 03/2009
17	Transplantation 02/2022 - 12/2003
13	Immunotherapy 05/2022 - 12/2009
11	Aftercare (After-Treatment) 08/2021 - 01/2007
10	Radiotherapy 11/2021 - 01/2012
9	Kidney Transplantation 04/2020 - 04/2002
7	Ligation 08/2019 - 08/2002
6	Neoadjuvant Therapy 05/2022 - 03/2012